Biomedical subjects

K Sertl

Publications and source records attributed to K Sertl.

39 records · Page 3Linked to original sources

PubMed1982

[Complications of the central venous feeding of mobilized patients with an all-in-one solution].

35 mobilized patients received continuous parenteral nutrition consisting of an all-in-one solution mixed together in this department right before use over a total period of 1155 days (mean per patient 33 days). The primary complication rate was: second puncture in 14%, pneumothorax in 11% and haemothorax in 3% of cases. Secondary complications: catheter-related sepsis was documented in 8.5%. Metabolic complications were not seen. The all-in-one solution is a satisfactory nutrient for long-term, low-risk administration by the route, suitable even in the case of mobilized patients, without the necessity of intensive metabolic monitoring.

Adult↗

PubMed1982

[Gluten-sensitive enteropathy and intestinal non-Hodgkin lymphoma (author's transl)].

The case report is presented of a patient with gluten sensitive enteropathy who subsequently developed an intestinal non-Hodgkin lymphoma. When steatorrhoea or diarrhoea develops in a patient with abdominal lymphoma, these symptoms are often attributed to progression of the lymphoma or to chemotherapy of the lymphoma. Since there is an established relationship between gluten-sensitive enteropathy and intestinal lymphoma, the differential diagnosis of steatorrhoea or diarrhoea developing in the course of malignant intestinal lymphoma must include gluten-sensitive enteropathy as well. In the investigation for gluten-sensitive enteropathy HLA typing can be used as a screening test in addition to routine malabsorption tests and small bowel biopsy

Adult↗

PubMed1980

[How dangerous is splenectomy in Hodgkin's disease? (author's transl)].

Serious complications aetiologically connected with the operation were found in 8 out of 51 patients (19 females, 32 males) who had undergone splenectomy for Hodgkin's disease. Weighing potential complications against the expected beneficial effects, clear indications for splenectomy are only found in stages I and IIa. In all more progressed clinical stages splenectomy should only be performed when 1) platelet deficiency existed prior to treatment, 2) additional irradiation of the splenic area is to be avoided, 3) oophoropexy is to be performed at the same time. When discussing the indication for splenectomy one should remember that a delay of treatment by approximately three weeks will result.

Adolescent↗